Randal Nardone And The Growth Of His Financial Services Career

Randal Nardone has a net worth of over $1.8 billion and is ranked 557th on Forbes’ billionaires list. This isn’t what people expected when Nardone was at the University of Connecticut working on his English and Biology undergraduate degrees. Even when he completed law school at Boston University and got his jurisprudence doctorate, few, if any, of the people that knew Randal Nardone imagined he would be a billionaire soon. However, when Nardone gave up practicing law and began to work in the financial services industry, he had gotten on a path that would lead to him becoming very wealthy.

For Randal Nardone, the journey to a lucrative career in finance began when he left Thacher Proffitt & Wood, the law firm where he was a partner and an executive committee member, and began to work with Blackrock Financial Management. Nardone left Blackrock in 1997, spent a year as managing director at UBS, then co-founded Fortress Investment Group Rob Kauffman and Wes Edens in 1998. The company enjoyed a meteoritic rise and by the time Fortress Investment Group held their IPO in 2007 and became America’s first publicly traded large private equity firm, the company had a valuation of between $5 billion and $7 billion.

On paper Randal Nardone and all the other co-founders were billionaires at that point. But such great wealth was not simply given to Nardone and the Fortress Investment team. It took years of hard work and long hours for the value of Fortress Investment Group to rise to such a high level. During that time Randal Nardone has honed his managerial, directorial, executive and financial services skills by spending an inordinate amount of time holding leadership positions in almost a dozen companies. He has also been a top executive in many of Fortress Investment Group’s subsidiaries.

Now a husband and father, Randal Nardone’s schedule is even more hectic. Plus, in 2013 he was named CEO at Fortress Investment Group. Nardone was also named director of Fortress Transportation and Infrastructure Investors LLC in 2015. But Nardone has long proven he can handle with aplomb the responsibilities that come with those positions. He’s now a financial services professional with over 25 years experience. Nardone has used his financial acumen, experience, knowledge and expertise to help companies in several industries to thrive. His background in English, biology, law and finance has helped to make Randal Nardone very successful.

For details: www.marketswiki.com/wiki/Randal_A._Nardone

Clay Siegall’s Marvelous Leadership Has Made Seattle Genetics Progress in Their Cancer Research Efforts

Seattle Genetics is one of the many companies that is making headway in cancer research in the recent past. Clay Siegall has been at the helm of the company, diligently helping in improving cancer patient’s lives. Since 2002, he has been the executive officer, and with great skills, he has led the company in making great strides in cancer research and innovative therapies.

Leadership and Growth

Throughout his career, Clay Siegall has been passionate about helping ease the pain for cancer patients. It’s with this drive that he has provided the much-needed leadership that has elevated Seattle Genetics to a position of executing high-end research developments. The company has since developed their first antibody drug conjugates, such as ADCETRIS. Clay Siegall played a big part in ensuring that ADCETRIS gained FDA approval in 2011. He, as well, helped popularize ADCETRIS around the world to ensure it reaches as many patients as possible.

Achievements and Awards

Besides his leadership role in new cancer therapies sector, Siegall has also helped in raising more than 1.2 billion dollars as capital for Seattle Genetics in private and public funding. Since its inception in 1998, Seattle Genetics has grown rapidly, with their stock having tripled in only less than half a decade under the able management of Clay Siegall. His efforts haven’t gone unrecognized as he was named the Entrepreneur of the Year in 2012. In 2013, he was granted the Maryland Alumnus of the Year for Natural Sciences, Math, and Computer.

Siegall’s Background

Clay Siegall spent three years at George Washington University and completed his Ph.D. in Genetics. He began working at the Bristol-Myers as a chief investigator. He rose through the ranks to the principal scientist post. He advanced to become a member of staff at the National Cancer Institute. Shortly after, Siegall participated in setting up Seattle Genetics.

Clay Siegall owns 15 patents and is still dedicated to looking for ways to improve cancer research. Clay Siegall has been generous to share his in-depth background in the medical field with the community. His passion for educating the scientific community has seen him publish more than 70 articles in medical and science matters.